Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-02-26 @ 11:03 AM
Study NCT ID:
NCT03662035
Status:
UNKNOWN
Last Update Posted:
2018-09-19
First Post:
2018-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer
Sponsor:
Changzhou No.2 People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ChangzhouNo2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None